Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Clinical Study on the Safety and Effectiveness of Vagus Nerve Stimulation in the Treatment of Refractory Depression [Phase 1, Phase 2]
Clinical trial update on safety and effectiveness of vagus nerve stimulation for refractory depression (Phase 1/Phase 2).
-
FDA label_change · 2019-11-05FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Wellbutrin SR, updating the labeling for the bupropion extended-release formulation following Gl…
-
FDA approval · 2019-11-05FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for WELLBUTRIN XL (bupropion hydrochloride) submitted by Bausch Health US LLC under NDA021515.
-
FDA approval · 2019-10-31FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Chartwell RX, LLC)
FDA approved Venlafaxine hydrochloride (extended-release) from Chartwell RX, LLC under an Original Application (ANDA).
-
FDA approval · 2019-10-30FDA Approved: DESVENLAFAXINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for desvenlafaxine (generic) sponsored by Hikma Pharmaceuticals USA Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-10-29FDA Approved: DESVENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' supplemental application for desvenlafaxine.
-
FDA approval · 2019-10-29FDA Approved: FLUOXETINE — Supplemental Application (Vensun Pharmaceuticals, Inc.)
FDA approved a supplemental application for a fluoxetine hydrochloride product from Vensun Pharmaceuticals, thereby approving a generic vers…
-
CLINICAL_TRIALS trial_result · 2019-10-28Clinical Trial Update: The Safety and Efficacy of Nexalin Trans-cranial Electrical Stimulation Stimulation for the Treatment of Depression [NA]
A completed clinical trial assessing the safety and efficacy of Nexalin transcranial electrical stimulation for depression with posted resul…
-
CLINICAL_TRIALS trial_result · 2019-10-24Clinical Trial Update: Post Marketing Study for the Evaluation of Predictix Antidepressant Clinician Software Support Tool in Prescribing Antidepressant Medication/s for the Treatment of Patients Suffering From Major Depressive Disorder [Phase 4]
Post-marketing Phase 4 study evaluating Predictix antidepressant clinician software support tool for prescribing antidepressants in major de…
-
CLINICAL_TRIALS research · 2019-10-15Clinical Trial Update: Brain Aging and Treatment Response in Geriatric Depression [Phase 4]
Phase 4 clinical trial update examining brain aging and treatment response in geriatric depression, with conditions including mild cognitive…
-
CLINICAL_TRIALS trial_result · 2019-10-14Clinical Trial Update: Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine [Phase 4]
Phase 4 clinical trial update on vortioxetine focusing on pattern separation, brain-derived neurotrophic factors, and mechanisms; trial term…
-
CLINICAL_TRIALS trial_result · 2019-10-11Clinical Trial Update: A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01) [Phase 3]
Phase 3 trial RAP-MD-01 studied rapastinel as adjunctive therapy in major depressive disorder; trial completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-11Clinical Trial Update: Veteran Peer-Assisted Computerized Cognitive Behavioral Therapy for Depression [NA]
Completed clinical trial evaluating veteran peer-assisted computerized cognitive behavioral therapy for depression; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: AV-101 as Adjunct Antidepressant Therapy in Patients With Major Depression [Phase 2]
Phase 2 clinical trial updating AV-101 as adjunct antidepressant therapy in patients with major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Mobile Technology to Engage and Link Patients and Providers in Antidepressant Treatment [NA]
Clinical trial update on using mobile technology to engage patients and providers in antidepressant treatment; study completed with results …
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22) [Phase 3]
Phase 3 clinical trial updates safety and efficacy of vilazodone in pediatric patients with major depressive disorder; results completed wit…
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: TMS for Adults With Autism and Depression [NA]
Clinical trial of transcranial magnetic stimulation (TMS) in adults with autism and depression has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-30Clinical Trial Update: Online Yoga for Individuals With Mood Disorders [NA]
A completed clinical trial assessing online yoga for individuals with mood disorders, including bipolar disorder and depression, with result…
-
FDA approval · 2019-09-30FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Ingenus Pharmaceuticals, LLC)
The FDA approved a Supplemental Application for Desipramine hydrochloride from Ingenus Pharmaceuticals, LLC, confirming continued market ava…
-
FDA approval · 2019-09-30FDA Approved: VILAZODONE HYDROCHLORIDE — Original Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva's generic vilazodone hydrochloride tablets as an original ANDA for the treatment of major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2019-09-27Clinical Trial Update: Managing Cancer and Living Meaningfully (CALM): A Study to Evaluate the Effectiveness of a Psychological Intervention for Cancer Patients [Phase 3]
Phase 3 study evaluating CALM, a psychological intervention for cancer patients with depression, completed.
-
CLINICAL_TRIALS trial_result · 2019-09-27Clinical Trial Update: Memantine to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Major Depression [NA]
Completed clinical trial investigating memantine to reduce neurocognitive deficits after unilateral electroconvulsive therapy for major depr…
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Oxytocin Add-on for Stable Depressed Patients [NA]
Clinical trial update on oxytocin add-on for stabilized depression patients; study terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: mHealth for Antenatal Mental Health
A completed clinical trial investigating mHealth interventions for antenatal depression in pregnant individuals, with results posted in 2019…
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: Escitalopram Plus PS128 vs. Escitalopram [Phase 4]
Phase 4 trial comparing escitalopram alone to escitalopram plus PS128 in major depression was terminated.